Bicycle therapeutics to participate in the svb securities global biopharma conference

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq:bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in a fireside chat at the svb securities global biopharma conference on february 15th, 2023 at 9:20 a.m. et. the conference will be held in a virtual meeting format.
BCYC Ratings Summary
BCYC Quant Ranking